Managing Rivaroxaban 17+

HealthObs Ltd

Designed for iPhone

    • Free

iPhone Screenshots


The Rivaroxaban App is designed for doctors to help them manage patients on the anticoagulant rivaroxaban. It will be useful to general practitioners, cardiologists, haematologists, neurologists, anaesthetists, emergency specialists and surgeons. In fact most clinicians will at some time have patients on anticoagulants and would find this App helpful.

The Rivaroxaban App will help you
• Provide dosing advice for your patient.
• Provide safe advice if bleeding occurs.
• Recommend when to stop treatment before surgery.
• Interpret coagulation results.

Features of the Rivaroxaban App

Dose recommendation
The Rivaroxaban App offers the correct dose for the correct indication in line with the published data sheet.

Drug information
Details of the common side-effects, potential drug interactions and basic pharmacology is immediately available.

Managing bleeding
Bleeding is a potential problem with any anticoagulant and can be complex to manage. The Rivaroxaban App provides advice about which treatments to use for both minor and major bleeding.

Managing surgery
A common question with any anticoagulant is how long should treatment be stopped before surgery? The Rivaroxaban App calculates a safe interval between stopping treatment and surgery and offers advice for treatment prior to emergency surgery if the surgery cannot be delayed.

Referenced information
All recommendations are linked to an information page which is appropriately referenced.

Website for feedback
The Rivaroxaban App is linked to the HealthObs website to allow you to ask questions, provide feedback or even start a discussion.

We welcome all feedback.


The advice is based on published reviews and guidelines. Extensive efforts have been made to ensure the accuracy of the information however information may change for specific countries at short notice. The user should refer to the manufacturers datasheet for complete prescribing information.

This software is to be used as a guide only and healthcare professionals should use clinical judgement and should individualise care for each patient. In no event shall the author or developer be liable to any party for damages resulting from the use of this application.

What’s New

Version 1.5

Added new indications for Rivaroxaban. Change in recommendations in renal impairment.

App Privacy

The developer, HealthObs Ltd, has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer's privacy policy.

No Details Provided

The developer will be required to provide privacy details when they submit their next app update.

More By This Developer

You Might Also Like